Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Identifying best methods for the detection of subtle cognitive decline

Award Number: R03AG070435
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/15/2021
PERIOD OF PERFORMANCE END DATE: 12/31/2023

Group Awards By:

View Award Description

Identifying best methods for the detection of subtle cognitive decline - PROJECT SUMMARY / ABSTRACT New submission for PAS-19-391 (Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses [R03]). Recent statistics show that if everyone alive in 2018 who will develop Alzheimer’s disease (AD) had early and accurate diagnosis, there would be a savings of $7.9 trillion in medical and long-term care costs. Although the advent of Alzheimer’s disease (AD) biomarkers has revolutionized our understanding of AD pathogenesis during the preclinical phase, these approaches are often expensive, invasive, inaccessible due to rural location, cost, or medical contraindications. Additionally, beyond a focus on AD biomarkers alone, it is essential to emphasize that cognitive difficulties and subsequent functional impairment are the features of the disease that negatively impact the lives of patients and their families. Emerging evidence suggests that subtle cognitive changes may develop much earlier than originally described in models of AD and these subtle cognitive changes add meaningful prognostic value, above and beyond AD biomarkers, in predicting progression to mild cognitive impairment (MCI) and dementia. The gold standard approach for identifying subtle cognitive decline in preclinical AD, however, remains unclear. Therefore, we propose to apply four different classification algorithms for subtle cognitive decline in the open source Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. The four classifications methods include two subjective approaches: self-reported subjective cognitive decline (Self-SCD) and informant-reported subjective cognitive decline (Inform-SCD); and two objective approaches: a sensitive neuropsychological individual test-based approach called objectively-defined subtle cognitive decline (Obj-SCD) and a composite score-based approach using the preclinical Alzheimer’s cognitive composite to identify subtle cognitive decline (PACC-SCD). The specific aims of this proposal include: 1) Compare AD biomarkers across 4 subtle cognitive decline definitions (Self-SCD, Inform-SCD, Obj-SCD, and PACC-SCD); 2) Determine which subtle cognitive decline definitions best capture objective cognitive decline in the year preceding the subtle cognitive decline classification; and 3) Examine longitudinal a) clinical and b) biomarker progression across subtle cognitive decline definitions to determine the definitions with the best predictive utility. Results of the proposed aims will likely impact the design of future studies, as having simple, yet reliable, and highly cost- efficient methods for narrowing the initial pool of participants so that only those at greatest risk require a PET scan for screening purposes would result in significant cost-savings. Additionally, these results will serve as critical preliminary data for future grant applications, and be a key step toward improving clinically meaningful early detection methods of those at risk for future decline, particularly those with limited access to AD biomarker testing.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	000	2	5/6/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $158,000 )
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	001	2	4/25/2022	NON-COMPETING CONTINUATION	$15,800
2022	2022	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	000	2	12/17/2021	NON-COMPETING CONTINUATION	$142,200
														Subtotal = $158,000

Issue Date FY: 2021 ( Subtotal = $157,750 )
2021	2021	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Aging Research	000	1	1/14/2021	NEW	$157,750
														Subtotal = $157,750

Grand Total All Awards = $315,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Identifying best methods for the detection of subtle cognitive decline

Award Number: R03AG070435

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/15/2021

PERIOD OF PERFORMANCE END DATE: 12/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer